Lake Street Maintains Evaxion Biotech(EVAX.US) With Buy Rating, Maintains Target Price $6

Moomoo NewsFeb 14 09:31 ET · Ratings

Evaxion Biotech Re-established Compliance With Nasdaq

TipRanksFeb 14 08:10 ET

Nasdaq Confirms Evaxion Is Fully Compliant, Withdraws Delisting Determination

GlobeNewswireFeb 14 08:00 ET

Evaxion Biotech Expands Capital Through ADS Offering

TipRanksFeb 12 08:27 ET

Evaxion Biotech Shares Are Trading Lower. The Stock May Be Moving on Continued Weakness After Lake Street Cut Its Price Target on the Stock Yesterday From $35 to $6.

BenzingaFeb 5 07:52 ET

Express News | Evaxion Biotech Shares Are Trading Lower. The Stock May Be Moving on Continued Weakness After Lake Street Cut Its Price Target on the Stock Yesterday From $35 to $6

BenzingaFeb 5 07:52 ET